These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17670846)

  • 1. Activation of the signal transducer and activator of transcription-1 in diffuse proliferative lupus nephritis.
    Martinez-Lostao L; Ordi-Ros J; Balada E; Segarra-Medrano A; Majó-Masferrer J; Labrador-Horrillo M; Vilardell-Tarrés M
    Lupus; 2007; 16(7):483-8. PubMed ID: 17670846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predominance of Th1 immune response in diffuse proliferative lupus nephritis.
    Masutani K; Akahoshi M; Tsuruya K; Tokumoto M; Ninomiya T; Kohsaka T; Fukuda K; Kanai H; Nakashima H; Otsuka T; Hirakata H
    Arthritis Rheum; 2001 Sep; 44(9):2097-106. PubMed ID: 11592372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of signal transducer and activator of transcription 3 correlates with cell proliferation and renal injury in human glomerulonephritis.
    Arakawa T; Masaki T; Hirai T; Doi S; Kuratsune M; Arihiro K; Kohno N; Yorioka N
    Nephrol Dial Transplant; 2008 Nov; 23(11):3418-26. PubMed ID: 18556750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glomerular expression of toll-like receptor-9 in lupus nephritis but not in normal kidneys: implications for the amplification of the inflammatory response.
    Papadimitraki ED; Tzardi M; Bertsias G; Sotsiou E; Boumpas DT
    Lupus; 2009 Aug; 18(9):831-5. PubMed ID: 19578108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential for glomerular C4d as an indicator of thrombotic microangiopathy in lupus nephritis.
    Cohen D; Koopmans M; Kremer Hovinga IC; Berger SP; Roos van Groningen M; Steup-Beekman GM; de Heer E; Bruijn JA; Bajema IM
    Arthritis Rheum; 2008 Aug; 58(8):2460-9. PubMed ID: 18668574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated levels of fractalkine expression and accumulation of CD16+ monocytes in glomeruli of active lupus nephritis.
    Yoshimoto S; Nakatani K; Iwano M; Asai O; Samejima K; Sakan H; Terada M; Harada K; Akai Y; Shiiki H; Nose M; Saito Y
    Am J Kidney Dis; 2007 Jul; 50(1):47-58. PubMed ID: 17591524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glomerular expression of monocyte chemoattractant protein-1 is predictive of poor renal prognosis in pediatric lupus nephritis.
    Marks SD; Williams SJ; Tullus K; Sebire NJ
    Nephrol Dial Transplant; 2008 Nov; 23(11):3521-6. PubMed ID: 18495743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical expression of activated caspase-3 as a marker of apoptosis in glomeruli of human lupus nephritis.
    Jeruc J; Vizjak A; Rozman B; Ferluga D
    Am J Kidney Dis; 2006 Sep; 48(3):410-8. PubMed ID: 16931214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlative insights into immunoexpression of monocyte chemoattractant protein-1, transforming growth factor beta-1 and CD68+ cells in lupus nephritis.
    Wagrowska-Danilewicz M; Stasikowska O; Danilewicz M
    Pol J Pathol; 2005; 56(3):115-20. PubMed ID: 16334978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predominance of CD8+ T lymphocytes among periglomerular infiltrating cells and link to the prognosis of class III and class IV lupus nephritis.
    Couzi L; Merville P; Deminière C; Moreau JF; Combe C; Pellegrin JL; Viallard JF; Blanco P
    Arthritis Rheum; 2007 Jul; 56(7):2362-70. PubMed ID: 17599764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulation of apoptosis: a possible mechanism leading to chronic progressive renal histological changes in lupus nephritis.
    Lu F; Shen W; Zhang X; Guo M; Lin S
    Chin Med J (Engl); 2000 Dec; 113(12):1082-6. PubMed ID: 11776141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal expression of galectin-3 in systemic lupus erythematosus patients with nephritis.
    Kang EH; Moon KC; Lee EY; Lee YJ; Lee EB; Ahn C; Song YW
    Lupus; 2009 Jan; 18(1):22-8. PubMed ID: 19074165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCR3+CD4+ T cells are enriched in inflamed kidneys and urine and provide a new biomarker for acute nephritis flares in systemic lupus erythematosus patients.
    Enghard P; Humrich JY; Rudolph B; Rosenberger S; Biesen R; Kuhn A; Manz R; Hiepe F; Radbruch A; Burmester GR; Riemekasten G
    Arthritis Rheum; 2009 Jan; 60(1):199-206. PubMed ID: 19116922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glomerular c4d staining can be an indicator of disease activity in lupus nephritis.
    Sahin OZ; Gurses S; Taslı F; Yavas H; Ersoy R; Uzum A; Cirit M
    Ren Fail; 2013; 35(2):222-5. PubMed ID: 23176021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognosis and pathogenesis of severe lupus glomerulonephritis.
    Schwartz MM; Korbet SM; Lewis EJ;
    Nephrol Dial Transplant; 2008 Apr; 23(4):1298-306. PubMed ID: 18045825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors of clinical outcome in patients with diffuse proliferative lupus nephritis treated early by intravenous methylprednisolone pulse therapy.
    Kanno A; Hotta O; Yusa N; Taguma Y
    Ren Fail; 2007; 29(1):41-7. PubMed ID: 17365909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High levels of complement C3a receptor in the glomeruli in lupus nephritis.
    Mizuno M; Blanchin S; Gasque P; Nishikawa K; Matsuo S
    Am J Kidney Dis; 2007 May; 49(5):598-606. PubMed ID: 17472841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in diffuse proliferative lupus nephritis.
    Abraham MA; Korula A; Jayakrishnan K; John GT; Thomas PP; Jacob CK
    J Assoc Physicians India; 1999 Sep; 47(9):862-5. PubMed ID: 10778652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of proliferating cell associated protein, Ki-67, supports cellular proliferation in WHO Class IV lupus nephritis.
    Cheah PL; Kunaseegaran R; Looi LM
    Malays J Pathol; 2001 Jun; 23(1):27-30. PubMed ID: 16329544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term efficacy and safety of quadruple therapy in childhood diffuse proliferative lupus nephritis.
    Demircin G; Oner A; Erdoğan O; Delibaş A; Baysun S; Bülbül M; Bek K; Oksal A
    Ren Fail; 2008; 30(6):603-9. PubMed ID: 18661410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.